|
Drugs: cardiovascular system
Citations 1-4 of 4 total displayed.
|
Most recent content
(1 Aug 2006):
|
- Quality improvement reports
Oral anticoagulation in a pediatric hospital: impact of a quality improvement initiative on warfarin management strategies
- B S Moffett, A L Parham, C D Caudilla, A R Mott, and K D Gurwitch
Qual Saf Health Care 2006; 15: 240-243.
[Abstract]
[Full text]
- Original Articles
Overprescribing of lipid lowering agents
- M A Smith, E D Cox, and J M Bartell
Qual Saf Health Care 2006; 15: 251-257.
[Abstract]
[Full text]
|
Past content
(since Sep 2002):
|
- Original Articles
Pursuing integration of performance measures into electronic medical records: beta-adrenergic receptor antagonist medications
- M Weiner, T E Stump, C M Callahan, J N Lewis, and C J McDonald
Qual Saf Health Care 2005; 14: 99-106.
[Abstract]
[Full text]
- Original Articles
Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues
- P Underwood and P Beck
Qual Saf Health Care 2002; 11: 230-232.
[Abstract]
[Full text]
|
|